ICU Medical (ICUI) Tops Q1 EPS by 18c

ICU Medical (NASDAQ: ICUI) reported Q1 EPS of $1.81, $0.18 better than the analyst estimate of $1.63. Revenue for the quarter came in at $328.6 million versus the consensus estimate of $296.3 million.

Vivek Jain, ICU Medical’s Chief Executive Officer, said, “First quarter results were generally in line with our expectations except for some additional demand within our IV Solutions business due to the COVID-19 pandemic.”

GUIDANCE:

ICU Medical sees FY2020 EPS of $5.95-$6.65, versus prior of $6.50-$7.20 and the consensus of $6.87.

For earnings history and earnings-related data on ICU Medical (ICUI) click here.

You May Also Be Interested In

• ICU Medical Announces Second Quarter 2026 Results and Updates its Fiscal Year 2026 Guidance
• King Pharmaceuticals (KG) Misses Q2 EPS by 103c
• MetaVia Inc. (MTVA) Tops Q2 EPS by 73c